347 related articles for article (PubMed ID: 15371341)
21. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
[TBL] [Abstract][Full Text] [Related]
22. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
[TBL] [Abstract][Full Text] [Related]
23. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
Zhang H; Jin Y; Chen X; Jin C; Law S; Tsao SW; Kwong YL
Cancer Lett; 2007 Jan; 245(1-2):184-94. PubMed ID: 16488074
[TBL] [Abstract][Full Text] [Related]
24. HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function.
Liu X; Roberts J; Dakic A; Zhang Y; Schlegel R
Virology; 2008 Jun; 375(2):611-23. PubMed ID: 18367227
[TBL] [Abstract][Full Text] [Related]
25. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.
Martinez-Zapien D; Ruiz FX; Poirson J; Mitschler A; Ramirez J; Forster A; Cousido-Siah A; Masson M; Vande Pol S; Podjarny A; Travé G; Zanier K
Nature; 2016 Jan; 529(7587):541-5. PubMed ID: 26789255
[TBL] [Abstract][Full Text] [Related]
26. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.
Stutz C; Reinz E; Honegger A; Bulkescher J; Schweizer J; Zanier K; Travé G; Lohrey C; Hoppe-Seyler K; Hoppe-Seyler F
PLoS One; 2015; 10(7):e0132339. PubMed ID: 26151636
[TBL] [Abstract][Full Text] [Related]
27. The DNA repair protein, O(6)-methylguanine-DNA methyltransferase is a proteolytic target for the E6 human papillomavirus oncoprotein.
Srivenugopal KS; Ali-Osman F
Oncogene; 2002 Aug; 21(38):5940-5. PubMed ID: 12185595
[TBL] [Abstract][Full Text] [Related]
28. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
[TBL] [Abstract][Full Text] [Related]
29. The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes.
Bedard KM; Underbrink MP; Howie HL; Galloway DA
J Virol; 2008 Apr; 82(8):3894-902. PubMed ID: 18256157
[TBL] [Abstract][Full Text] [Related]
30. NFX1 plays a role in human papillomavirus type 16 E6 activation of NFkappaB activity.
Xu M; Katzenellenbogen RA; Grandori C; Galloway DA
J Virol; 2010 Nov; 84(21):11461-9. PubMed ID: 20739528
[TBL] [Abstract][Full Text] [Related]
31. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.
Drews CM; Brimer N; Vande Pol SB
PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989
[TBL] [Abstract][Full Text] [Related]
32. Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53.
Niebler M; Qian X; Höfler D; Kogosov V; Kaewprag J; Kaufmann AM; Ly R; Böhmer G; Zawatzky R; Rösl F; Rincon-Orozco B
PLoS Pathog; 2013; 9(8):e1003536. PubMed ID: 23935506
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus E6 regulates the cytoskeleton dynamics of keratinocytes through targeted degradation of p53.
Cooper B; Brimer N; Vande Pol SB
J Virol; 2007 Nov; 81(22):12675-9. PubMed ID: 17804489
[TBL] [Abstract][Full Text] [Related]
34. PinX1, a novel target gene of p53, is suppressed by HPV16 E6 in cervical cancer cells.
Wu G; Liu D; Jiang K; Zhang L; Zeng Y; Zhou P; Zhong D; Gao M; He F; Zheng Y
Biochim Biophys Acta; 2014 Feb; 1839(2):88-96. PubMed ID: 24412852
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase.
Gao Q; Kumar A; Singh L; Huibregtse JM; Beaudenon S; Srinivasan S; Wazer DE; Band H; Band V
Cancer Res; 2002 Jun; 62(11):3315-21. PubMed ID: 12036950
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitin-dependent proteolysis of trihydrophobin 1 (TH1) by the human papilloma virus E6-associated protein (E6-AP).
Yang Y; Liu W; Zou W; Wang H; Zong H; Jiang J; Wang Y; Gu J
J Cell Biochem; 2007 May; 101(1):167-80. PubMed ID: 17131388
[TBL] [Abstract][Full Text] [Related]
37. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent.
Tomaić V; Pim D; Banks L
Virology; 2009 Oct; 393(1):7-10. PubMed ID: 19700180
[TBL] [Abstract][Full Text] [Related]
38. Telomerase activation by the E6 gene product of human papillomavirus type 16.
Klingelhutz AJ; Foster SA; McDougall JK
Nature; 1996 Mar; 380(6569):79-82. PubMed ID: 8598912
[TBL] [Abstract][Full Text] [Related]
39. Long-term persistent infection of HPV 16 E6 up-regulate SP1 and hTERT by inhibiting LKB1 in lung cancer cells.
Yang JH; Li XY; Wang X; Hou WJ; Qiu XS; Wang EH; Wu GP
PLoS One; 2017; 12(8):e0182775. PubMed ID: 28813465
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus type 16 E6 and NFX1-123 mislocalize immune signaling proteins and downregulate immune gene expression in keratinocytes.
Levan J; Vliet-Gregg PA; Robinson KL; Katzenellenbogen RA
PLoS One; 2017; 12(11):e0187514. PubMed ID: 29117186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]